References - Therapeutic Strategies in Cancer Biology and Pathology - page 209

Feng, M., Huang, B., Du, Z., Xu, X., Chen, Z., 2011b. DLC-1 as a modulator of
proliferation, apoptosis and migration in Burkitt's lymphoma cells. Mol. Biol. Rep. 38,
1915-1920.
Feng, S., Cong, S., Zhang, X., Bao, X., Wang, W., Li, H., et al., 2011c. MicroRNA-192 target-
ing retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer
cells. Nucleic Acids Res. 39, 6669-6678.
Fenton, H., Carlile, B., Montgomery, E.A., Carraway, H., Herman, J., Sahin, F., et al., 2006.
LKB1 protein expression in human breast cancer. App. Immunohist. Mol. Morphol. 14,
146-153.
Fernandez-Fernandez, M.R., Veprintsev, D.B., Fersht, A.R., 2005. Proteins of the S100 family
regulate the oligomerization of p53 tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 102,
4735-4740.
Ferreira, A.C., Suriano, G., Mendes, N., Gomes, B., Wen, X., Carneiro, F., et al., 2012.
E-cadherin impairment increases cell survival through Notch-dependent upregulation of
Bcl-2. Hum. Mol. Genet. 21, 334-343.
Ferrigno, O., Lallemand, F., Verrecchia, F., L'Hoste, S., Camonis, J., Atfi, A., et al., 2002. Yes-
associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity
against TGF-beta/Smad signalling. Oncogene 21, 4879-4884.
Fillmore, C.M., Kuperwasser, C., 2008. Human breast cancer cell lines contain stem-like cells
that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Breast Cancer Res. 10, R25.
Finoux, A.L., Chartrand, P., 2008. Oncogenic and tumour suppressor microRNAs. Med. Sci.
24, 1049-1054.
Fitzgerald, M., Oshiro, M., Holtan, N., Krager, K., Cullen, J.J., Futscher, B.W., et al., 2003.
Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic
control. Neoplasia 5, 427-436.
Fleuriel, C., Touka, M., Boulay, G., Guérardel, C., Rood, B.R., Leprince, D., 2009. HIC1
(hypermethylated in cancer 1) epigenetic silencing in tumors. Int. J. Biochem. Cell. Biol.
41, 26-33.
Foekens, J.A., Sieuwerts, A.M., Smid, M., Look, M.P., de Weerd, V., Boersma, A.W.M., et al.
2008. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen
receptor-positive human breast cancer. Proc. Natl. Acad. Sci. USA 105, 13021-13026.
Foley, N.H., Bray, I.M., Tivnan, A., Bryan, K., Murphy, D.M., Buckley, P.G., et al., 2010.
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threo-
nine kinase AKT2. Mol. Cancer 9, 83.
Fonseca-Sanchez, M.A., Cuevas, S.R., Mendoza-Hernandez, G., Bautista-Pina, V., Ocampo,
E.A., Miranda, A.H., et al., 2012. Breast cancer proteomics reveals a positive correlation
between glyoxalase 1 expression and high tumor grade. Int. J. Oncol. 41, 670-680.
Fontemaggi, G., Dell'Orso, S., Trisciuoglio, D., Shay, T., Melucci, E., Fazi, F., et al. 2009.
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-
angiogenesis. Nat. Struct. Mol. Biol. 16, 1086-1093.
Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., et al., 2011. COSMIC:
mining complete cancer genomes in the catalogue of somatic mutations in cancer.
Nucleic Acids Res. 39, D945-D950.
Ford, J.C., Alkhodairy, F., Fotou, E., Sheldrick, K.S., Griffiths, D.J., Carr, A.M., 1994.
14-3-3-Protein homologues required for the DdNA damage checkpoint in fission yeast.
Science 265, 533-535.
Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Calin, G.A., et al., 2010. MiR-199a-3p regu-
lates mTOR and c-Met to influence the Doxorubicin sensitivity of human hepatocarci-
noma cells. Cancer Res. 70, 5184-5193.